Manufacturer or GPO Program year 2021 Source: CMS Open Payments

Boehringer Ingelheim MENA (Scientific Office) FZ-LLC

United Arab Emirates

CMS manufacturer 100000061373

Open in the dashboard

General payments

$190,403

42 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2021, Boehringer Ingelheim MENA (Scientific Office) FZ-LLC reported paying $190,403 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2021 General $77,804 26
2020 General $5,180 2
2019 General $107,419 14

Breakdown

Top recipients General payments · program year 2021
  1. Sanjay Kaul Los Angeles, CA $22,620 7 payments
  2. Javed Butler Advanced Heart Failure and Transplant Cardiology · Jackson, MS $13,250 4 payments
  3. Sripal Bangalore Interventional Cardiology · New York, NY $12,266 3 payments
  4. Steven Kahn Seattle, WA $9,500 4 payments
  5. Darren McGuire Cardiovascular Disease · Dallas, TX $7,830 3 payments
  6. George Bakris Endocrinology, Diabetes & Metabolism · Chicago, IL $6,394 2 payments
  7. Augusto Caballero-Robles Endocrinology, Diabetes & Metabolism · Boston, MA $3,145 2 payments
  8. Dinesh Khanna Rheumatology · Ann Arbor, MI $2,800 1 payment
Products the payments named General payments · program year 2021
  1. Jardiance Diabetes $33,260 61% · 4 recipients
  2. Micardis Cardiovascular $18,659 34% · 2 recipients
  3. Ofev Respiratory $2,800 5% · 1 recipient

Each share is of this company’s general payments naming a product in 2021. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2021
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $13,250 29% · 1 practitioner
  2. Interventional Cardiology Internal Medicine $12,266 27% · 1 practitioner
  3. Endocrinology, Diabetes & Metabolism Internal Medicine $9,539 21% · 2 practitioners
  4. Cardiovascular Disease Internal Medicine $7,830 17% · 1 practitioner
  5. Rheumatology Internal Medicine $2,800 6% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. California $22,620 29% · 1 recipient
  2. Mississippi $13,250 17% · 1 recipient
  3. New York $12,266 16% · 1 recipient
  4. Washington $9,500 12% · 1 recipient
  5. Texas $7,830 10% · 1 recipient

The top 5 of 8 states; each share is of this company’s general payments in 2021 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2021
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $169,598 33 payments
  2. Travel and Lodging $20,145 5 payments
  3. Food and Beverage $660 4 payments
Companies with a similar name General payments · program years 2019–2021
  1. Boehringer Ingelheim Pharmaceuticals, Inc. CT, United States $119,273,072
  2. Boehringer Ingelheim International GmbH Germany $23,700,916
  3. Boehringer Ingelheim RCV GmbH & Co KG Austria $1,008,478
  4. Boehringer Ingelheim Pharma GmbH & Co.KG Germany $565,806
  5. Boehringer Ingelheim (Phil.) Inc. Philippines $156,755
  6. Boehringer Ingelheim Singapore Pte. Ltd. Singapore $135,030
  7. Boehringer Ingelheim b.v. Netherlands $129,191
  8. Boehringer Ingelheim Do Brasil Quimica e Farmaceutical Ltda. Brazil $112,993
  9. Boehringer Ingelheim Pty Ltd Australia $91,255
  10. Boehringer Ingelheim Canada Ltd.Ltee Canada $87,239

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 34.

42 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record